 | John Y. M. Koo, Chai Sue Lee - 2003 - 495 sayfa
...markers of disease activity in atopic dermatitis. Br J Dermatol 2002; 147:71—79. 144. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002; 46:1—23. 145. Ellis CN, Krueger GO. Alefacept Clinical Study Group. Treatment of chronic... | |
 | Michael Sticherling, Enno Christophers - 2003 - 200 sayfa
...topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 346: 321-327 Krueger JG (2002) The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 46: 1-23 Kurt/, ES, Bayley SC, Arshad F. Lee AA. Pr/ekop PA (1995) Leflunomide: an active... | |
 | Kenneth B. Gordon - 2005 - 280 sayfa
...(15HETE) formation in uninvolved psoriatic dermis. Arch Dermatol 122:877—880 63. Krueger JG (2002) The immunologic basis for the treatment of psoriasis with new biologic agents. Am Acad Dermatol 46:1—23 64. Krueger GG, Bergstmesser PR, Lowe NJ, Voorhees JJ, Weinstein GD (1984)... | |
 | Kenneth A. Arndt, Jeffrey T. S. Hsu - 2007 - 412 sayfa
...be irritating and lead to a more widespread eruption and chronic course. References 1. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents./ Am Acad Dermatol 2002;46:1-23. 2. Sano S, Chan KS, Carbajal S, et al. Stat 3 links activated keratinocytes... | |
 | Frederick W. Alt - 2006 - 296 sayfa
...conformationdependent epitope of human platelet glycoprotein Ilia. J. Biol. Chem. 265, 20594-20601. Krueger, JG (2002). The immunologic basis for the treatment of psoriasis with new biologic agents. /. Am. Acad. Dermatol. 46, 1-23, quiz 23-26. Krueger, JG, and Bowcock, A. (2005). Psoriasis pathophysiology:... | |
| |
The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermato! 